Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Kangsheng Pharmaceutical, commonly known as ZKES, is a China-based pharmaceutical company specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates as a comprehensive pharmaceutical enterprise with a strong focus on anti-infectives, cardiovascular treatments, and gastrointestinal medications. ZKES maintains significant manufacturing capabilities, including GMP-certified facilities for the production of various chemical drugs and intermediates. In addition to its own product portfolio, the company provides contract manufacturing and development services to global partners, leveraging its expertise in chemical synthesis and large-scale production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZKES.